These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 8340056)

  • 21. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
    Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
    Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of hyperglycemia on glucose uptake and hepatic glucose production in non-dialyzed uremic patients.
    Schmitz O; Arnfred J; Orskov L; Nielsen OH; Orskov H; Posborg V
    Clin Nephrol; 1988 Jul; 30(1):27-34. PubMed ID: 2905213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone and carbohydrate intolerance in cirrhosis.
    Shankar TP; Solomon SS; Duckworth WC; Jerkins T; Iyer RS; Bobal MA
    Horm Metab Res; 1988 Sep; 20(9):579-83. PubMed ID: 3058569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients.
    Butler PC; Rizza RA
    Diabetes; 1991 Jan; 40(1):73-81. PubMed ID: 2015976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide treatment does not improve impaired glucose uptake in cirrhosis.
    Shmueli E; Orskov H; Alberti KG; Record CO
    Horm Metab Res; 1993 Jun; 25(6):317-20. PubMed ID: 8344648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance.
    Saccà L; Orofino G; Petrone A; Vigorito C
    J Clin Invest; 1984 Jun; 73(6):1683-7. PubMed ID: 6373828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus in chronic active hepatitis and cirrhosis.
    Kingston ME; Ali MA; Atiyeh M; Donnelly RJ
    Gastroenterology; 1984 Sep; 87(3):688-94. PubMed ID: 6086443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate-induced thermogenesis in liver cirrhosis: glucose vs. fructose.
    Martines D; Martines V; Pasini M; Cocco G; Lora L; Varnier M; Venier GB; Sammartano G; Naccarato R
    Nutrition; 1994; 10(6):521-6. PubMed ID: 7703598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measurement of carbohydrate oxidation by means of indirect continuous calorimetry in normal and diabetic subjects].
    Magnenat G; Felber JP; Curchod B; Gomez F; Pittet P; Bonjour JP; Weissbrodt P; Geser CA; Muller-Hess R; Jéquier E
    Schweiz Med Wochenschr; 1975 Jan; 105(3):69-73. PubMed ID: 1121656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
    Guillon J; Charbonnel B
    Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal and metabolic changes in hepatic cirrhosis.
    Johnston DG; Alberti KG; Binder C; Faber OK; Wright R; Orskov H
    Horm Metab Res; 1982 Jan; 14(1):34-9. PubMed ID: 7037586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance and carbohydrate oxidation in patients with chemical diabetes.
    Chevaux F; Curchod B; Felber JP; Jéquier E
    Diabete Metab; 1982 Jun; 8(2):105-8. PubMed ID: 7049777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.